These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 23252394)
1. Coordination of copper to the membrane-bound form of α-synuclein. Dudzik CG; Walter ED; Abrams BS; Jurica MS; Millhauser GL Biochemistry; 2013 Jan; 52(1):53-60. PubMed ID: 23252394 [TBL] [Abstract][Full Text] [Related]
2. Coordination features and affinity of the Cu²+ site in the α-synuclein protein of Parkinson's disease. Dudzik CG; Walter ED; Millhauser GL Biochemistry; 2011 Mar; 50(11):1771-7. PubMed ID: 21319811 [TBL] [Abstract][Full Text] [Related]
3. Comparing the copper binding features of alpha and beta synucleins. Rodríguez EE; Ríos A; Trujano-Ortiz LG; Villegas A; Castañeda-Hernández G; Fernández CO; González FJ; Quintanar L J Inorg Biochem; 2022 Apr; 229():111715. PubMed ID: 35074552 [TBL] [Abstract][Full Text] [Related]
4. Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein. Smith DP; Tew DJ; Hill AF; Bottomley SP; Masters CL; Barnham KJ; Cappai R Biochemistry; 2008 Feb; 47(5):1425-34. PubMed ID: 18179253 [TBL] [Abstract][Full Text] [Related]
5. Structural characterization of a high affinity mononuclear site in the copper(II)-α-synuclein complex. Bortolus M; Bisaglia M; Zoleo A; Fittipaldi M; Benfatto M; Bubacco L; Maniero AL J Am Chem Soc; 2010 Dec; 132(51):18057-66. PubMed ID: 21141829 [TBL] [Abstract][Full Text] [Related]
6. The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells. Fares MB; Ait-Bouziad N; Dikiy I; Mbefo MK; Jovičić A; Kiely A; Holton JL; Lee SJ; Gitler AD; Eliezer D; Lashuel HA Hum Mol Genet; 2014 Sep; 23(17):4491-509. PubMed ID: 24728187 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders. Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160 [TBL] [Abstract][Full Text] [Related]
8. Cu2+ binding modes of recombinant alpha-synuclein--insights from EPR spectroscopy. Drew SC; Leong SL; Pham CL; Tew DJ; Masters CL; Miles LA; Cappai R; Barnham KJ J Am Chem Soc; 2008 Jun; 130(24):7766-73. PubMed ID: 18494470 [TBL] [Abstract][Full Text] [Related]
9. Remote His50 Acts as a Coordination Switch in the High-Affinity N-Terminal Centered Copper(II) Site of α-Synuclein. De Ricco R; Valensin D; Dell'Acqua S; Casella L; Dorlet P; Faller P; Hureau C Inorg Chem; 2015 May; 54(10):4744-51. PubMed ID: 25926427 [TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein binds large unilamellar vesicles as an extended helix. Trexler AJ; Rhoades E Biochemistry; 2009 Mar; 48(11):2304-6. PubMed ID: 19220042 [TBL] [Abstract][Full Text] [Related]
11. Bioinorganic Chemistry of Parkinson's Disease: Affinity and Structural Features of Cu(I) Binding to the Full-Length β-Synuclein Protein. Miotto MC; Pavese MD; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO Inorg Chem; 2017 Sep; 56(17):10387-10395. PubMed ID: 28820253 [TBL] [Abstract][Full Text] [Related]
12. Evidence for copper-dioxygen reactivity during alpha-synuclein fibril formation. Lucas HR; Debeer S; Hong MS; Lee JC J Am Chem Soc; 2010 May; 132(19):6636-7. PubMed ID: 20423081 [TBL] [Abstract][Full Text] [Related]
13. Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation. Binolfi A; Lamberto GR; Duran R; Quintanar L; Bertoncini CW; Souza JM; Cerveñansky C; Zweckstetter M; Griesinger C; Fernández CO J Am Chem Soc; 2008 Sep; 130(35):11801-12. PubMed ID: 18693689 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's Protein α-Synuclein Binds Efficiently and with a Novel Conformation to Two Natural Membrane Mimics. Kumar P; Segers-Nolten IM; Schilderink N; Subramaniam V; Huber M PLoS One; 2015; 10(11):e0142795. PubMed ID: 26588454 [TBL] [Abstract][Full Text] [Related]
16. Membrane insertion exacerbates the α-Synuclein-Cu(II) dopamine oxidase activity: Metallothionein-3 targets and silences all α-synuclein-Cu(II) complexes. Calvo JS; Mulpuri NV; Dao A; Qazi NK; Meloni G Free Radic Biol Med; 2020 Oct; 158():149-161. PubMed ID: 32712192 [TBL] [Abstract][Full Text] [Related]
17. Probing conformational change of intrinsically disordered α-synuclein to helical structures by distinctive regional interactions with lipid membranes. Lee SJ; Lee JW; Choi TS; Jin KS; Lee S; Ban C; Kim HI Anal Chem; 2014 Feb; 86(3):1909-16. PubMed ID: 24383916 [TBL] [Abstract][Full Text] [Related]
18. The role of His-50 of α-synuclein in binding Cu(II): pH dependence, speciation, thermodynamics and structure. Valensin D; Camponeschi F; Luczkowski M; Baratto MC; Remelli M; Valensin G; Kozlowski H Metallomics; 2011 Mar; 3(3):292-302. PubMed ID: 21212878 [TBL] [Abstract][Full Text] [Related]
19. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein. O'Leary EI; Jiang Z; Strub MP; Lee JC J Biol Chem; 2018 Jul; 293(28):11195-11205. PubMed ID: 29853639 [TBL] [Abstract][Full Text] [Related]
20. Effect of dioxygen on copper(II) binding to alpha-synuclein. Lucas HR; Lee JC J Inorg Biochem; 2010 Mar; 104(3):245-9. PubMed ID: 20064662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]